A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer

Brachytherapy

Volumn 12, Issue 5, 2013, Pages 428-433

  Spratt, Daniel E ^a   Scala, Lawrence M ^a   Folkert, Michael ^a   Voros, Laszlo ^a   Cohen, Gil'ad N ^a   Happersett, Laura ^a   Katsoulakis, Evangelia ^a   Zelefsky, Michael J ^a   Kollmeier, Marisa A ^a   Yamada, Yoshiya ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brachytherapy; Dosimetry; High dose rate; Prostate cancer; Stereotactic body radiotherapy

Indexed keywords

IRIDIUM 192;

ARTICLE; BLADDER; BRACHYTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HUMAN; HUMAN TISSUE; MONOTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RECTUM; STEREOTACTIC BODY RADIATION THERAPY; URETHRA;

BRACHYTHERAPY; DOSIMETRY; HIGH-DOSE RATE; PROSTATE CANCER; STEREOTACTIC BODY RADIOTHERAPY;

BRACHYTHERAPY; HUMANS; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; RADIOTHERAPY, HIGH-ENERGY; TREATMENT OUTCOME;

EID: 84883560522     PISSN: 15384721     EISSN: 18731449     Source Type: Journal    
DOI: 10.1016/j.brachy.2013.03.003     Document Type: Article

References (25)

1. Yoshioka Y., Nose T., Yoshida K., et al. High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial. Int J Radiat Oncol Biol Phys 2000, 48:675-681.
2. Martinez A.A., Pataki I., Edmundson G., et al. Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: A feasibility report. Int J Radiat Oncol Biol Phys 2001, 49:61-69.
3. Corner C., Rojas A.M., Bryant L., et al. A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancer. Int J Radiat Oncol Biol Phys 2008, 72:441-446.
4. Ghadjar P., Keller T., Rentsch C.A., et al. Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy. Brachytherapy 2009, 8:45-51.
5. Barkati M., Williams S.G., Foroudi F., et al. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A Phase II trial. Int J Radiat Oncol Biol Phys 2012, 82:1889-1896.
6. Grills I.S., Martinez A.A., Hollander M., et al. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds. J Urol 2004, 171:1098-1104.
7. Fuller D.B., Naitoh J., Lee C., et al. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: Dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Int J Radiat Oncol Biol Phys 2008, 70:1588-1597.
8. Jabbari S., Weinberg V.K., Kaprealian T., et al. Stereotactic body radiotherapy as monotherapy or post-external beam radiotherapy boost for prostate cancer: Technique, early toxicity, and PSA response. Int J Radiat Oncol Biol Phys 2012, 82:228-234.
9. Lloyd-Davies R.W., Collins C.D., Swan A.V. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). Urology 1990, 36:107-111.
10. Collins C.D., Lloyd-Davies R.W., Swan A.V. Radical external beam radiotherapy for localised carcinoma of the prostate using a hypofractionation technique. Clin Oncol (R Coll Radiol) 1991, 3:127-132.
11. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 1999, 43:1095-1101.
12. Fowler J., Chappell R., Ritter M. Is alpha/beta for prostate tumors really low?. Int J Radiat Oncol Biol Phys 2001, 50:1021-1031.
13. Wang J.Z., Li X.A., Yu C.X., et al. The low alpha/beta ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?. Int J Radiat Oncol Biol Phys 2003, 57:1101-1108.
14. Mohler J.L. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Canc Netw 2010, 8:145.
15. Spratt D.E., Pei X., Yamada J., et al. Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2013, 85:686-692.
16. Yamada Y., Bhatia S., Zaider M., et al. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer. Brachytherapy 2006, 5:157-164.
17. Yamada Y., Rogers L., Demanes D.J., et al. American Brachytherapy Society consensus guidelines for high-dose-rate prostate brachytherapy. Brachytherapy 2012, 11:20-32.
18. Arcangeli S., Scorsetti M., Alongi F. Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review. Crit Rev Oncol Hematol 2012, 84:101-108.
19. Katz A.J., Santoro M., Ashley R., et al. Stereotactic body radiotherapy for organ-confined prostate cancer. BMC Urol 2010, 10:1.
20. Freeman D.E., King C.R. Stereotactic body radiotherapy for low-risk prostate cancer: Five-year outcomes. Radiat Oncol 2011, 6:3.
21. Pawlicki T., Kim G.Y., Hsu A., et al. Investigation of linac-based image-guided hypofractionated prostate radiotherapy. Med Dosim 2007, 32:71-79.
22. Wallner K., Merrick G., Sutlief S., et al. High-dose regions versus likelihood of cure after prostate brachytherapy. Int J Radiat Oncol Biol Phys 2005, 62:170-174.
23. Deutsch I., Zelefsky M.J., Zhang Z., et al. Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT. Brachytherapy 2010, 9:313-318.
24. Brandeis J., Pashos C.L., Henning J.M., et al. A nationwide charge comparison of the principal treatments for early stage prostate carcinoma. Cancer 2000, 89:1792-1799.
25. Nguyen P.L., Gu X., Lipsitz S.R., et al. Cost implications of the rapid adoption of newer technologies for treating prostate cancer. J Clin Oncol 2011, 29:1517-1524.